Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis

Medicine and Dentistry

• Sevelamer 100%
• Phosphate Binder 85%
• Isotopes of Calcium 71%
• Calcification 57%
• Patient 57%
• Cardiovascular System 42%
• Hemodialysis 42%
• Hyperphosphatemia 42%
• Calcium Acetate 42%
• Inpatient 42%
• Serum 28%
• End Stage Renal Disease 28%
• Health Care Cost 28%
• Mortality 28%
• Phosphorus 14%
• Chronic Kidney Disease 14%
• Bone Disease 14%
• Low Density Lipoprotein Cholesterol 14%
• Bone Metabolism 14%
• Secondary Hyperparathyroidism 14%
• Evaluation Study 14%
• Renal Osteodystrophy 14%
• Therapeutic Procedure 14%
• Motivation 14%
• Kidney 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Sevelamer 100%
• Phosphate Binding Agent 85%
• Calcium 71%
• Calcification 57%
• Hemodialysis 42%
• Calcium Acetate 42%
• Hyperphosphatemia 42%
• End Stage Renal Disease 28%
• Mortality 28%
• Phosphorus 14%
• Chronic Kidney Failure 14%
• Low Density Lipoprotein Cholesterol 14%
• Dialysis 14%
• Secondary Hyperparathyroidism 14%
• Renal Osteodystrophy 14%